FDA flags Class I Omnipod 5 pod recall over insulin leak risk
The FDA says certain Omnipod 5 pods are part of a Class I recall because a manufacturing defect may let insulin leak inside the pod. The notice says affected users should stop using impacted pods, check lot numbers, and switch to unaffected pods or contact Insulet for replacements.
Certain Omnipod 5 pods are part of a Class I recall, the FDA’s most serious recall classification. The issue does not involve all Omnipod products. It affects specific pod lots that may leak insulin inside the device, which can lead to too little insulin being delivered.
For people who rely on insulin, that matters because missed insulin can cause blood sugar to rise quickly and, in severe cases, lead to diabetic ketoacidosis, or DKA. The FDA says affected pods should not be used.
What happened
The FDA says Insulet identified a manufacturing defect in certain Omnipod 5 pods. In some pods, a small tear in internal tubing can let insulin leak inside the pod instead of entering the body as intended. The FDA’s recall database says the problem can cause under-delivery of insulin and, in some cases, a shutoff in delivery.
The agency classified the issue as a Class I recall after later updates to the notice. Insulet said the correction applies only to specific lots, not every Omnipod 5 pod or every Omnipod product.
Who may be affected
This recall applies only to certain lot numbers. The FDA says users should check the lot number on the pod tray lid, the box, or the pod itself. Insulet also set up an online lot-checking tool and phone support for replacement requests.
If your pods are not in the affected lots, the FDA says they remain okay to use under the recall notice.
Why the recall matters
When insulin is under-delivered, blood glucose can rise. MedlinePlus explains that diabetes is a condition in which blood sugar levels are too high and insulin helps move glucose from the blood into cells. If insulin delivery is interrupted, people may develop high blood sugar symptoms and, in more serious cases, DKA.
The FDA says the issue may not always trigger an alarm, so users should not assume a lack of warning means the pod is working properly.
What users should do now
- Do not use pods from affected lots.
- If an affected pod is already in use, replace it with a pod from an unaffected lot.
- Check the lot number before using any new pod.
- Request replacement pods through Insulet.
- If you do not have enough pods, contact your health care provider about backup insulin delivery options.
Warning signs and urgent steps
The FDA says prolonged high blood sugar from under-delivery can lead to DKA, which needs prompt medical treatment. If blood sugar stays high after a pod change, or if a person has trouble getting glucose back under control, they should contact a clinician right away. If symptoms are severe or the person seems very ill, seek urgent or emergency care.
The bottom line
This recall is limited to certain Omnipod 5 pod lots, but it is serious enough that the FDA classified it as a Class I recall. The safest next step is to check lot numbers, stop using affected pods, and use replacement pods or another insulin-delivery plan if needed.
Sources
Editorial note: Weence articles are researched from cited public-health, medical, regulatory, journal, and reputable news sources and may be drafted with AI assistance. They are checked for source support, clarity, and safety guardrails before publication.
This article is for general informational purposes only and is not medical advice. Research findings can be early or incomplete, and health guidance can change. Always talk with a qualified healthcare professional about personal symptoms, diagnosis, medications, vaccines, screenings, or treatment decisions. If you think you may have a medical emergency, call emergency services right away.
